✦ LIBER ✦

Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids

✍ Scribed by Perrem, Kilian; Bryan, Tracy M; Englezou, Anna; Hackl, Torben; Moy, Elsa L; Reddel, Roger R

Book ID: 110062176
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 252 KB
Volume: 18
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1202752

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alternative lengthening of telomeres in

Alternative lengthening of telomeres in mammalian cells

✍ Henson, Jeremy D; Neumann, Axel A; Yeager, Thomas R; Reddel, Roger R 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 806 KB

Telomere maintenance in wilms tumors: Fi

Telomere maintenance in wilms tumors: First evidence for the presence of alternative lengthening of telomeres mechanism

✍ Lorenza Venturini; Maria Grazia Daidone; Rosita Motta; Paola Collini; Filippo Sp 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB

## Abstract Unlimited proliferative potential is a hallmark of cancer, and can be achieved through the activation of telomere maintenance mechanisms (TMMs). Most tumors activate telomerase, but a significant minority, mainly of mesenchymal origin, uses a recombination‐based, alternative lengthening

Alternative lengthening of telomeres in

Alternative lengthening of telomeres in hTERT-inhibited laryngeal cancer cells

✍ Wei Chen; Bo-Kui Xiao; Jun-Ping Liu; Shi-Ming Chen; Ze-Zhang Tao 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 956 KB

Topoisomerase IIIα is required for norma

Topoisomerase IIIα is required for normal proliferation and telomere stability in alternative lengthening of telomeres

✍ Temime-Smaali, Nassima; Guittat, Lionel; Wenner, Thomas; Bayart, Emilie; Douarre 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 350 KB

Evidence for alternative lengthening of

Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies

✍ Jennie N. Jeyapalan; Aaron Mendez-Bermudez; Nadia Zaffaroni; Yuri E. Dubrova; Ni 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 454 KB

## Abstract Immortalized and cancer cells maintain their telomeres by activation of a telomere maintenance mechanism (TMM). In ∼85% of cancers telomerase is activated (TA) but in some tumours, in particular sarcomas, an alternative lengthening of telomeres (ALT) pathway is used. Liposarcomas are th

Divergent patterns of telomere maintenan

Divergent patterns of telomere maintenance mechanisms among human sarcomas: Sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas

✍ Gary A. Ulaner; Andrew R. Hoffman; Jesse Otero; Hsuan-Ying Huang; Zhiquan Zhao; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

## Abstract Two types of telomere maintenance mechanisms (TMMs) have been described in human tumors: telomerase activation and alternative lengthening of telomeres (ALT). Although the vast majority of epithelial tumors rely on telomerase activation, many mesenchymal tumors rely on ALT for telomere